Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05079269

Pre-op Fluid Study

Effect of Pre-operative Intravenous Crystalloids on Post-Induction Blood Pressure

Status
Active Not Recruiting
Phase
N/A
Study type
Interventional
Enrollment
550 (actual)
Sponsor
Medical University of Graz · Academic / Other
Sex
All
Age
45 Years
Healthy volunteers
Not accepted

Summary

Theoretical framework: Hypotension during surgery directly impacts patients' postoperative outcomes and complications. Decrease in blood pressure measurements secondary to anesthetic drugs is an expected scenario in most surgical cases. Moreover, hypovolemia secondary to fast pre-operative period may facilitate post-induction hypotension which can be compensated by fluid bolus pre-operatively.

Detailed description

Objectives: The purpose of the study is to conduct a randomized intervention cohort study using pre-operative fluid therapy to assess its effect on blood pressure during the post-induction period. The investigators are testing the hypothesis that preoperative Crystalloid bolus decreases the risk of post-induction hypotension, specifically the time-weighted average (TWA) mean arterial pressure (MAP) under 65 mmHg during the first 20 minutes after anaesthetic induction or until surgical incision, whichever is first, compared to standard of care, which is minimal fluid administration in the pre-operative period. Methods: The investigators will conduct a randomized intervention cohort study using pre-operative fluid therapy to assess its effect on blood pressure during the post-induction period. The intervention group will receive a bolus of a balanced crystalloid solution within 60 ± 15 minutes before induction of anaesthesia. The control group will be treated according to the current clinical standard of care. The investigators will compare the time-weighted average (TWA) mean arterial pressure (MAP) under 65 mmHg during the first 20 minutes after anaesthetic induction or until surgical incision (whichever comes first).

Conditions

Interventions

TypeNameDescription
OTHERCrystalloid SolutionsAs above

Timeline

Start date
2021-11-01
Primary completion
2024-06-19
Completion
2025-11-30
First posted
2021-10-15
Last updated
2025-11-21

Locations

2 sites across 1 country: Austria

Source: ClinicalTrials.gov record NCT05079269. Inclusion in this directory is not an endorsement.